glp 1 agonist or antagonist Classification of currently available glucagon-like peptide-1 receptor The GLP-1 Agonists and Obesity:
Description
With GLP-1 medications like semaglutide and tirzepatide making headlines, many Americans are still unclear on how these treatments work, what the FDA allows, and where to find safe information
Burns, G
KFF research found that 54% of adults who have taken GLP-1 drugs reported difficulty affording the therapy, with 22% stating it was very difficult. Geographic disparities: Patients in rural or underserved areas tend to face significant disparities in accessing GLP-1 therapies
These findings point to a central mechanism underlying increased sympathetic outflow
